Skip header and navigation

Narrow By

64 records – page 1 of 4.

Managing fluid intake

https://libcat.nshealth.ca/en/permalink/chpams35130
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0127
Available Online
View Pamphlet
Our bodies need fluid to work properly. The kidneys, liver, and heart work to keep fluids in balance. Sometimes, fluid builds up in our bodies. With some medical conditions, you may need to limit your fluid intake. This pamphlet lists signs that fluid may be building up in your body and tips for managing your fluid intake.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Edema - prevention & control
Kidney Diseases - diet therapy
Subjects (LCSH)
Edema
Kidneys--Diseases--Nutritional aspects
Specialty
Nephrology
Food and nutrition
Abstract
Our bodies need fluid to work properly. The kidneys, liver, and heart work to keep fluids in balance. Sometimes, fluid builds up in our bodies. With some medical conditions, you may need to limit your fluid intake. This pamphlet lists signs that fluid may be building up in your body and tips for managing your fluid intake.
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
0127
Less detail

Nutrition guidelines for hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35132
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0628
Available Online
View Pamphlet
This pamphlet is for people with Chronic Kidney Disease (CKD). It gives information about protein, sodium (salt), potassium, and phosphorus, as well as reading food labels, adding calories and flavour, and controlling your fluid intake. A sample meal plan and guidelines for measuring portions are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (26 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diet therapy
Phosphorus, Dietary
Diet, Sodium-Restricted
Renal Dialysis
Subjects (LCSH)
Kidneys--Diseases--Nutritional aspects
Diet therapy
Food--Phosphorus content
Salt-free diet
Hemodialysis
Specialty
Nutrition and food
Abstract
This pamphlet is for people with Chronic Kidney Disease (CKD). It gives information about protein, sodium (salt), potassium, and phosphorus, as well as reading food labels, adding calories and flavour, and controlling your fluid intake. A sample meal plan and guidelines for measuring portions are included.
Notes
Previous title: Nutrition guidelines for kidney disease
Previous title: Diet for kidney disease
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
0628
Less detail

Sample meal plan for kidney disease

https://libcat.nshealth.ca/en/permalink/chpams35277
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0652
Available Online
View Pamphlet
This pamphlet gives a 14-day meal plan for people with kidney disease.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diet therapy
Subjects (LCSH)
Kidneys--Diseases--Nutritional aspects
Abstract
This pamphlet gives a 14-day meal plan for people with kidney disease.
Notes
Previous title: Sample renal diet plan
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
0652
Less detail

Treatment of high potassium with Kayexalate powder in hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1445
Available Online
View Pamphlet
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Polystyrene sulfonic acid
Hyperkalemia
Subjects (LCSH)
Drugs
Low-potassium diet
Specialty
Nephrology
Medications
Abstract
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
Notes
Previous title: Treatment of high potassium with Kayexalate powder in hemodialysis patients
Responsibility
Prepared by: Renal Program
Pamphlet Number
1445
Less detail

Managing your fluid intake in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35545
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0538
Available Online
View Pamphlet
This pamphlet explains how to maintain an ideal balance of fluid in your body when managing chronic kidney disease.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diet therapy
Subjects (LCSH)
Kidneys--Diseases--Nutritional aspects
Abstract
This pamphlet explains how to maintain an ideal balance of fluid in your body when managing chronic kidney disease.
Notes
Previous title: Managing your fluid intake in chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
0538
Less detail

Erythropoieis-stimulating agents (ESAs) for people with chronic kidney disease (CKD) and active cancer or a history of cancer or stroke

https://libcat.nshealth.ca/en/permalink/chpams37446
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2217
Available Online
View Pamphlet
If you have chronic kidney disease (CKD), your health care provider may order erythropoieis-stimulating agent (ESA) medications for you. This pamphlet explains the risks and benefits of ESAs if you have CKD and active cancer, or a history of cancer or stroke.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Neoplasms
Stroke
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Cancer
Cerebrovascular disease
Abstract
If you have chronic kidney disease (CKD), your health care provider may order erythropoieis-stimulating agent (ESA) medications for you. This pamphlet explains the risks and benefits of ESAs if you have CKD and active cancer, or a history of cancer or stroke.
Notes
Previous title: Erythropoieis-stimulating agents (ESAs) for chronic kidney disease (CKD) : with active cancer or a history of cancer or stroke
Responsibility
Prepared by: Renal Program
Pamphlet Number
2217
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0613
Available Online
View Pamphlet
Angiotensin converting enzyme (ACE) inhibitors are medications that can be used to treat high blood pressure and certain heart conditions (like heart attacks, heart failure), and kidney disease. This pamphlet explains how to take and store these medications. Possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Angiotensin-Converting Enzyme Inhibitors
Subjects (LCSH)
Angiotensin converting enzyme--Inhibitors
Specialty
Medications
Abstract
Angiotensin converting enzyme (ACE) inhibitors are medications that can be used to treat high blood pressure and certain heart conditions (like heart attacks, heart failure), and kidney disease. This pamphlet explains how to take and store these medications. Possible side effects are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0613
Less detail

Pruritis (itchy skin) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams38252
Nova Scotia Health Authority. Renal Pharmacy Team, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2385
Available Online
View Pamphlet
Pruritis is an itchy feeling on or under your skin. This pamphlet explains what causes pruritis in people with CKD, what the symptoms are, how you can prevent it, and how your kidney team will treat it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Pharmacy Team
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases
Pruritis
Subjects (LCSH)
Kidney disease
Skin
Itching
Abstract
Pruritis is an itchy feeling on or under your skin. This pamphlet explains what causes pruritis in people with CKD, what the symptoms are, how you can prevent it, and how your kidney team will treat it.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
2385
Less detail
Nova Scotia Health Authority. Emergency Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0240
Available Online
View Pamphlet
This pamphlet explains what causes kidney stones, symptoms, what to expect while you are in the Emergency Department, and follow-up.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Emergency Services
Alternate Title
Renal colic
Renal calculi
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Kidney Calculi
Subjects (LCSH)
Kidneys--Calculi
Specialty
Emergency
Abstract
This pamphlet explains what causes kidney stones, symptoms, what to expect while you are in the Emergency Department, and follow-up.
Responsibility
Prepared by: Emergency Services
Pamphlet Number
0240
Less detail

Living kidney donor discharge instructions

https://libcat.nshealth.ca/en/permalink/chpams38285
Nova Scotia Health Authority. Urology, Nova Scotia Health Authority. Multi Organ Transplant Program, Nova Scotia Health Authority. Nephrology. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2407
Available Online
View Pamphlet
This pamphlet gives information on how to heal and stay healthy after your kidney donation surgery. Topics include incision (cut) care, activity, feelings after surgery, medications, Post Donation Program, and symptoms that require a trip to the Emergency Department.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Urology
Nova Scotia Health Authority. Multi Organ Transplant Program
Nova Scotia Health Authority. Nephrology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Transplant Donors
Kidney transplantation
Subjects (LCSH)
Transplantation of organs, tissues, etc
Kidneys--Transplantation
Specialty
Nephrology
Abstract
This pamphlet gives information on how to heal and stay healthy after your kidney donation surgery. Topics include incision (cut) care, activity, feelings after surgery, medications, Post Donation Program, and symptoms that require a trip to the Emergency Department.
Responsibility
Prepared by: Urology/Multi Organ Transplant Program/Nephrology
Pamphlet Number
2407
Less detail

Prevnar® 20 (Pneumococcal Conjugate Vaccine) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams38309
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2427
Available Online
View Pamphlet
Prevnar® 20 is a vaccine that protects against infections caused by Streptococcus pneumoniae bacteria. This pamphlet explains why you may need to get vaccinated, possible side effects of the vaccine, and who should not get the vaccine.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases
Vaccines
Subjects (LCSH)
Kidneys--Diseases
Vaccines
Abstract
Prevnar® 20 is a vaccine that protects against infections caused by Streptococcus pneumoniae bacteria. This pamphlet explains why you may need to get vaccinated, possible side effects of the vaccine, and who should not get the vaccine.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2427
Less detail

Parathyroidectomy and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams34702
Nova Scotia Health Authority. Nephrology/Dialysis Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0739
Available Online
View Pamphlet
Parathyroidectomy is a surgery that removes your parathyroid glands. Your parathyroid glands are in your neck (usually on the back of the thyroid gland). They help to control your blood calcium and phosporous levels. Hyperparathyroidism is when one or more of the parathyroid glands makes too much parathyroid hormone in your blood. If this happens, you will need a parathyroidectomy. This pamphlet explains what a parathyroidectomy is, the possible complications with this surgery, care after surge…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nephrology/Dialysis Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Parathyroidectomy
Kidney Diseases
Subjects (LCSH)
Parathyroidectomy
Kidneys--Diseases
Specialty
Nephrology
Surgery
Abstract
Parathyroidectomy is a surgery that removes your parathyroid glands. Your parathyroid glands are in your neck (usually on the back of the thyroid gland). They help to control your blood calcium and phosporous levels. Hyperparathyroidism is when one or more of the parathyroid glands makes too much parathyroid hormone in your blood. If this happens, you will need a parathyroidectomy. This pamphlet explains what a parathyroidectomy is, the possible complications with this surgery, care after surgery, how to take care of your incision, blood work, medications, and symptoms that need medical attention right away. A medication chart is included.
Responsibility
Prepared by: Nephrology/Dialysis Services
Pamphlet Number
0739
Less detail

Acute hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35036
Nova Scotia Health Authority. QEII. Nephrology Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1151
Available Online
View Pamphlet
Hemodialysis is a treatment that uses a machine to filter your blood and remove waste and extra water from your blood. Topics include: what your kidneys do, what acute kidney failure is, what peritoneal dialysis is, what hemodialysis is, and how to live with kidney disease. A resource list is also given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Nephrology Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Acute Kidney Injury
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Acute renal failure
Abstract
Hemodialysis is a treatment that uses a machine to filter your blood and remove waste and extra water from your blood. Topics include: what your kidneys do, what acute kidney failure is, what peritoneal dialysis is, what hemodialysis is, and how to live with kidney disease. A resource list is also given.
Responsibility
Prepared by: Nephrology Services
Pamphlet Number
1151
Less detail

In-centre hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35162
Nova Scotia Health Authority. Central Zone. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1220
Available Online
View Pamphlet
This pamphlet is for patients who are beginning dialysis. It explains what to expect when starting hemodialysis, common questions you may have, your hemodialysis schedule, and your hemodialysis health care team. Information about Patient Rights and Responsibilities, Patient Relations, and Ethics is included. The pamphlet also includes a list of resources and words you may hear during your treatment. A blank Hemodialysis Care Plan, Hemodialysis Tracking Sheet, and Hemodialysis checklist are also…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Renal Program
Alternate Title
In centre hemodialysis
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (24 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Kidneys--Diseases
Specialty
Nephrology
Abstract
This pamphlet is for patients who are beginning dialysis. It explains what to expect when starting hemodialysis, common questions you may have, your hemodialysis schedule, and your hemodialysis health care team. Information about Patient Rights and Responsibilities, Patient Relations, and Ethics is included. The pamphlet also includes a list of resources and words you may hear during your treatment. A blank Hemodialysis Care Plan, Hemodialysis Tracking Sheet, and Hemodialysis checklist are also included.
Notes
Previous titles: Renal (dialysis) patient handbook, Hemodialysis patient handbook
Responsibility
Prepared by: Renal Program, Central Zone
Pamphlet Number
1220
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1466
Less detail

Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1465
Available Online
View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Cinacalcet
Renal Insufficiency, Chronic - drug therapy
Hyperparathyroidism, Secondary - drug therapy
Subjects (LCSH)
Chronic renal failure
Hyperparathyroidism
Kidneys--Diseases--Treatment
Abstract
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
Notes
Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
Responsibility
Prepared by: Renal Program
Pamphlet Number
1465
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1464
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1469
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Renal anemia
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1495
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1495
Less detail

64 records – page 1 of 4.